ALKS 2680, Placebo to match ALKS 2680, ALKS 2680, ALKS 2680 clinical trials

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2

This study is testing a new medicine, ALKS 2680, for adults with Narcolepsy Type 2. We want to see if it helps reduce sleepiness and improve daily life compared to a dummy pill. It's a key step to confirm if the medicine works and is safe.